Search for: "Ranbaxy Inc"
Results 61 - 80
of 142
Sort by Relevance
|
Sort by Date
26 Apr 2011, 11:15 pm
Ranbaxy Laboratories manufactured an Accutane version called Sotret which has been withdrawn. [read post]
13 Apr 2011, 5:13 pm
District Court for the District of Arizona (Phoenix Division) against Eisai, Inc. and Eisai Medical Research, Inc. [read post]
9 Mar 2011, 3:00 am
Allergan, Inc (Chicago IP Litigation Blog) Synagis (Palivizumab) – US: PDL BioPharma settles Medimmune Synagis litigation for $93M (Patent Docs) TriCor (Fenofibrate) – US: Abbott and Elan end TriCor suit with Ranbaxy (Patent Docs) Valsartan – Norway: Oslo District Court holds Actavis’ Valsartan/HCTZ product infringes Novartis’ patent covering synthesis route for Valsartan; deals inter alia with scope of Valsartan SPC (The SPC Blog) [read post]
17 Jan 2011, 9:27 am
USA, Inc. v. [read post]
29 Dec 2010, 2:57 am
Ferring Pharmaceuticals, Inc et al. [read post]
11 Oct 2010, 12:59 pm
Brooks Brothers, Inc. in which the Court addressed standing under 35 U.S.C. [read post]
6 Oct 2010, 11:43 pm
Apotex, Inc., 540 F.3d 1353 (Fed. [read post]
6 Oct 2010, 4:31 pm
By Jason RantanenTeva Pharmaceuticals USA, Inc. v. [read post]
7 Sep 2010, 6:10 pm
Genpharm Inc. et al. [read post]
1 Sep 2010, 6:49 am
Apotex, Inc. [read post]
18 Aug 2010, 12:19 am
Ranbaxy Laboratories Ltd. et al. [read post]
10 Aug 2010, 8:44 pm
Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while judging novelty:… [read post]
8 Aug 2010, 8:32 pm
• Defendants: Ranbaxy Laboratories Ltd.; Ranbaxy Pharmaceuticals Inc.; Ranbaxy, Inc.; Ethypharm S.A. [read post]
28 Jul 2010, 12:06 am
Ranbaxy Laboratories Inc. [read post]
21 Jul 2010, 9:49 pm
Pfizer Inc. et al. v. [read post]
16 Jul 2010, 8:43 am
Power-One, Inc., 2008 WL 1734833, at *12 (E.D. [read post]
16 Jul 2010, 7:14 am
Ranbaxy Laboratories Inc., 2-10-cv-00121 (TXED July 14, 2010, Report & Recommendations) (Everingham, M.J.) [read post]
16 Jun 2010, 3:02 pm
Ranbaxy Laboratories Ltd. et al. [read post]
19 May 2010, 6:15 am
Immutopics, Inc. [read post]
13 May 2010, 9:59 pm
Medicis argued further that Ranbaxy Inc. aided, abetted,... [read post]
